- Home
- BLFS vs NRK Comparison
BLFS vs NRK Comparison
Compare BLFS & NRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLFS
- NRK
- Stock Information
- Founded
- BLFS 1987
- NRK 2002
- Country
- BLFS United States
- NRK United States
- Employees
- BLFS N/A
- NRK N/A
- Industry
- BLFS Medical/Dental Instruments
- NRK Trusts Except Educational Religious and Charitable
- Sector
- BLFS Health Care
- NRK Finance
- Exchange
- BLFS Nasdaq
- NRK Nasdaq
- Market Cap
- BLFS 1.0B
- NRK 922.1M
- IPO Year
- BLFS 1989
- NRK N/A
- Fundamental
- Price
- BLFS $22.23
- NRK $9.36
- Analyst Decision
- BLFS Strong Buy
- NRK
- Analyst Count
- BLFS 7
- NRK 0
- Target Price
- BLFS $30.57
- NRK N/A
- AVG Volume (30 Days)
- BLFS 508.1K
- NRK 187.3K
- Earning Date
- BLFS 08-07-2025
- NRK 01-01-0001
- Dividend Yield
- BLFS N/A
- NRK 4.10%
- EPS Growth
- BLFS N/A
- NRK N/A
- EPS
- BLFS N/A
- NRK N/A
- Revenue
- BLFS $87,762,000.00
- NRK N/A
- Revenue This Year
- BLFS $21.21
- NRK N/A
- Revenue Next Year
- BLFS $17.58
- NRK N/A
- P/E Ratio
- BLFS N/A
- NRK N/A
- Revenue Growth
- BLFS 34.80
- NRK N/A
- 52 Week Low
- BLFS $19.10
- NRK $8.95
- 52 Week High
- BLFS $29.55
- NRK $11.09
- Technical
- Relative Strength Index (RSI)
- BLFS 52.34
- NRK 21.80
- Support Level
- BLFS $21.94
- NRK $9.70
- Resistance Level
- BLFS $22.98
- NRK $9.41
- Average True Range (ATR)
- BLFS 0.92
- NRK 0.06
- MACD
- BLFS 0.12
- NRK -0.03
- Stochastic Oscillator
- BLFS 63.31
- NRK 1.00
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
About NRK Nuveen New York AMT-Free Quality Municipal Income Fund
Nuveen New York AMT-Free Quality Municipal Income Fund is a closed-end investment company. Its investment objective is to provide current income exempt from regular federal, New York State, and New York City income taxes and from the federal alternative minimum tax applies to individuals and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.